Shire, which operates out of the U.S. but has its domicile in Ireland for tax reasons, will build its first manufacturing facility in its adopted country.

Now that the FDA has for the first time approved a company switching production of a drug from batch to continuous manufacturing, the agency is inviting others…

Teva expects to close on its buyout of Allergan’s generic drug business, but for now, Allergan is responsible for the recall of more than 50 lots, consisting…

German generics unit Fresenius Kabi issued two separate voluntary recalls for injectables produced at its plant in Illinois.

South Korea's Hanmi Science recently bought a swath of land near Yantai where it will spend about $200 million to build a manufacturing plant and R&D…

Pfizer's Consumer Healthcare is pulling tens of thousands of bottles of one of its adult Robitussin products in the U.S. due to a labeling issue. It comes…

Despite a stumbling economy in recent years, Russia still holds a lot of appeal as an emerging market for drugmakers. Japan's Eisai is planning a major…

With hundreds of cell and gene therapies percolating in clinics, a newly formed CDMO sees opportunity and says it's preparing to cash in on that with…

Indian pharma companies will face growing challenges in the U.S. as fewer big drugs will be losing their patents in the coming years with increased competition…

Teva is set to start manufacturing activities at a newly-expanded facility in Hungary following a HUF 2.3 billion ($8.4 million) project to bolster capacity…